Role of Class B Scavenger Receptor Type I in Phagocytosis of Apoptotic Rat Spermatogenic Cells by Sertoli Cells*

Akiko ShiratsuchiDagger §, Yuki Kawasaki§, Mamoru Ikemoto, Hiroyuki Arai, and Yoshinobu NakanishiDagger §parallel

From the Dagger  Faculty of Pharmaceutical Sciences and the § Graduate School of Natural Science and Technology, Kanazawa University, Kanazawa, Ishikawa 920-0934, Japan and the  Graduate School of Pharmaceutical Sciences, University of Tokyo, Tokyo 113-0033, Japan

    ABSTRACT
Top
Abstract
Introduction
References

Rat Sertoli cells phagocytose apoptotic spermatogenic cells, which consist mostly of spermatocytes, in primary culture by recognizing phosphatidylserine (PS) exposed on the surface of degenerating spermatogenic cells. We compared the mode of phagocytosis using spermatogenic cells at different stages of spermatogenesis. Spermatogenic cells were separated into several groups based on their ploidy, with purities of 60-90%. When the fractionated spermatogenic cell populations were subjected to a phagocytosis assay, cells with ploidies of 1n, 2n, and 4n were almost equally phagocytosed by Sertoli cells. All the cell populations exposed PS on the cell surface, and phagocytosis of all cell populations was similarly inhibited by the addition of PS-containing liposomes. Class B scavenger receptor type I (SR-BI), a candidate for the PS receptor, was detected in Sertoli cells. Overexpression of the rat SR-BI cDNA increased the PS-mediated phagocytic activity of Sertoli cell-derived cell lines. Moreover, phagocytosis of spermatogenic cells by Sertoli cells was inhibited in the presence of an anti-SR-BI antibody. Finally, the addition of high density lipoprotein, a ligand specific for SR-BI, decreased both phagocytosis of spermatogenic cells and incorporation of PS-containing liposomes by Sertoli cells. In conclusion, SR-BI functions at least partly as a PS receptor, enabling Sertoli cells to recognize and phagocytose apoptotic spermatogenic cells at all stages of differentiation.

    INTRODUCTION
Top
Abstract
Introduction
References

Most physiological cell death is caused by apoptosis, and apoptotic cells are believed to immediately undergo heterophagic elimination by surrounding phagocytic cells, such as macrophages (reviewed in Refs. 1-3). However, the molecular basis underlying the phagocytosis of apoptotic cells remains to be clarified.

Apoptosis and subsequent phagocytosis also occur in areas where macrophages do not infiltrate, such as the brain and the testis. In the testis, more than half of the differentiating spermatogenic cells die, probably by apoptosis, before they mature into spermatozoa (reviewed in Refs. 4-8), although the mechanism and meaning of this phenomenon are unknown. The occurrence of spermatogenic cell apoptosis at various stages of differentiation has been reported (Refs. 9-13 and reviewed in Refs. 7 and 8). Only a limited number of apoptotic spermatogenic cells, however, are detectable when testis sections are histochemically examined. This may be due to the elimination of degenerating spermatogenic cells by testicular phagocytes at the early stage of apoptosis. Electron microscopic studies with rodent testis sections have shown that degenerating spermatogenic cells are engulfed by Sertoli cells, a type of testicular somatic cell (14-17). Some murine Sertoli cell lines show phagocytic activity against latex beads (18-20). Sertoli cells are thus likely to be responsible for eliminating apoptotic spermatogenic cells in the testis (21). However, little is known about the regulation of this Sertoli cell function.

We previously reported that primary cultured rat spermatogenic cells of 20-day-old rats, which mostly consisted of spermatocytes, underwent apoptosis and were phagocytosed by Sertoli cells (22). In the apoptotic spermatogenic cells, phosphatidylserine (PS),1 which is otherwise confined to the inner leaflet of the membrane bilayer, was translocated to the outer leaflet, and phagocytosis was inhibited in the presence of liposomes containing PS (23). In the present study, we examined whether spermatogenic cells at various stages of differentiation are phagocytosed by Sertoli cells in a manner similar to spermatocyte phagocytosis and tried to identify the PS receptor presumed to be present on the surface of Sertoli cells and to be responsible for recognition and subsequent phagocytosis of apoptotic spermatogenic cells.

    MATERIALS AND METHODS

Testicular Cell Preparation-- Dispersed testicular cells were prepared from testes dissected from either 20- or 45-day-old Donryu rats as described previously (24, 25). The dispersed spermatogenic cells were separated through a 2-4% (v/v) density gradient formed on a 20% cushion of Percoll (Amersham Pharmacia Biotech, Uppsala, Sweden) using a Celsep apparatus (Brinkmann Instruments) (26) according to the protocol supplied by the manufacturer. From six 20-day-old rats, 2-3 × 106 4n-rich cells and 6-10 × 105 2n-rich cells were obtained; and from 45-day-old rats, 1-2 × 107 1n-rich cells (first elution), 6-10 × 105 2n-rich cells, and 6-10 × 105 1n-rich cells (second elution) were obtained. Sertoli cells were isolated as described (23).

Phagocytosis Assay-- Phagocytosis of spermatogenic cells by Sertoli cells was performed as described previously (23) with a few modifications. In brief, spermatogenic cells that had been cultured without Sertoli cells for 14-15 h were labeled with biotin (NHS-LS-Biotin, Pierce) and added to Sertoli cell cultures maintained either in 96-well plates (Corning, Cambridge, MA) for phagocytosis of fractionated spermatogenic cells or in Lab-Tek Chamber Slides (Nalge Nunc, Naperville, IL) for phagocytosis of unfractionated spermatogenic cells of 20-day-old rats at a ratio of 10:1 spermatogenic cells/Sertoli cells. The culture was kept at 32.5 °C for 2 h, and unreacted spermatogenic cells were removed first by pipetting with phosphate-buffered saline and then by trypsin (0.5 mg/ml) treatment for 3 min at room temperature. The remaining cells were fixed, supplemented with fluorescein isothiocyanate (FITC)-labeled avidin (fluorescein-avidin D, Vector Labs, Inc., Burlingame, CA), and examined under a fluorescence/phase-contrast microscope (IX70, Olympus, Tokyo, Japan). The ratio of the number of Sertoli cells having fluorescent signals to total Sertoli cells was determined in each microscopic field. Six to eight fields from different culture wells were examined in each experiment, and the results were analyzed statistically. The means ± S.D. of a typical example from at least two independent experiments were taken as the phagocytic index.

Since Sertoli cell-derived cell lines only weakly attached to the culture container, the phagocytosis assay with these cells was slightly modified. The phagocytic cells and cultured spermatogenic cells were mixed and maintained at 32.5 °C for 2-3 h, and the cells were all detached from the culture container by treatment with 0.1% (w/v) trypsin and 0.02% (w/v) EDTA, placed on poly-D-lysine-coated glass slides, and further treated as described above.

Phospholipid Externalization Assay-- Cell-surface PS was detected using FITC-conjugated annexin V (Bender MedSystems, Vienna, Austria) as described previously (27). Spermatogenic cells were simultaneously treated with propidium iodide and FITC-conjugated annexin V and analyzed with a flow cytometer (EPICS XL, Coulter Corp., Hialeah, FL). The cells negative for propidium iodide staining, which were considered to retain integrity of the plasma membrane, were gated and analyzed for binding of the FITC-labeled probe.

Liposome and High Density Lipoprotein (HDL) Preparation-- Liposomes were prepared as described previously (28). PS-containing liposomes were composed of phosphatidylcholine (PC) and PS at a molar ratio of 7:3. Fluorescence-labeled liposomes were prepared with N-(lissamine rhodamine B sulfonyl)-L-alpha -phosphatidylethanolamine (Avanti Polar Lipids) at 1% of total phospholipids. Human HDL was prepared in the density range 1.063-1.21 g/ml from plasma by ultracentrifugation according to standard procedures (29).

Northern Blots-- Total RNA was prepared using acid guanidinium thiocyanate (30), and poly(A)-containing RNA was enriched by affinity chromatography (oligo(dT)-cellulose type 2, Collaborative Biomedical Products, Bedford, MA). The RNA was separated on a formaldehyde-containing 1.2% (w/v) agarose gel and blotted onto a nitrocellulose membrane (BA85, Schleicher & Schuell, Dassel, Germany). The membrane was probed with a DNA fragment derived from the human beta -actin pseudogene (31) or a cDNA of the hamster class B scavenger receptor type I (SR-BI) (32). The hybridization signals were visualized by autoradiography using x-ray film (X-AR, Eastman Kodak Co.). Electrophoresis, transfer, blotting, and hybridization were conducted according to standard procedures (33). The probes were labeled with 32P by random priming (33) using a commercial kit (Takara Shuzo, Otsu, Shiga, Japan).

Cloning of Rat Sertoli SR-BI cDNA-- Poly(A)-containing RNA (~6 µg) was prepared from Sertoli cells (1.8 × 108) of 20-day-old rats and used to make a cDNA library using a commercial kit (Great Lengths cDNA synthesis kit, CLONTECH). The cDNA was ligated with the lambda ZAPII vector (Stratagene, La Jolla, CA) and packaged using GigapackIII Gold (Stratagene). The library, containing 1 × 105 independent clones, was screened by hybridization with a probe of the hamster SR-BI cDNA. Final positive clones were sequenced using an automated DNA sequencer (ABI Prism 377, Perkin-Elmer).

Transfection of Sertoli Cell-derived Cell Lines with Rat Sertoli SR-BI cDNA-- Rat SR-BI cDNA was recloned into the pRc/CMV vector (Invitrogen, NV Leek, The Netherlands) and introduced into Sertoli cell-derived cultured cell lines 15P-1 (a gift from F. Cuzin) (19) and TM4 (obtained from the American Type Culture Collection, Rockville, MA) (34) by the calcium phosphate method using a commercial kit (Invitrogen), and the cells were selected by maintenance in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum and G418 (0.5 mg/ml) (Geneticin, Life Technologies, Inc.) at 32.5 °C for 7-14 days. The selected cells were cloned and used for further analyses.

Liposome Incorporation Assay-- Fluorescence-labeled liposomes were added to cultured cells at 0.2 mM, and the mixture was incubated for 1 h at 32.5 °C. The cells were washed with phosphate-buffered saline, and the extent of liposome incorporation was determined using either a flow cytometer or a fluorescence/phase-contrast microscope.

Latex Bead Incorporation Assay-- Sertoli cell-derived cell lines were mixed with fluorescence-labeled latex beads (Polybead Microparticles (ø = 0.75 µm), Polysciences, Warrington, PA) for 1 h at 37 °C, and incorporation of the beads was examined using either flow cytometry or microscopy.

Anti-SR-BI Antibody Preparation-- Peptides corresponding to amino acid residues 76-95 and 110-132 of hamster SR-BI (32) with an extra Cys residue at the carboxyl terminus were synthesized. The peptides were coupled to keyhole limpet hemocyanin, emulsified with Freund's adjuvant, and injected into the backs of New Zealand White rabbits. Anti-SR-BI antibodies were affinity-purified from the rabbit sera as described previously (35). Anti-SR-BI-76 and anti-SR-BI-110 stand for antibodies raised against peptides corresponding to amino acid residues 76-95 and 110-132, respectively. Anti-SR-BI-76 was used throughout the study, except that immunohistochemical analysis was done with anti-SR-BI-110.

Western Blotting-- Membrane fractions were prepared from liver and primary cultured Sertoli cells and spermatogenic cells of 20-day-old rats as described previously (36). The fractions were denatured under reducing conditions and separated on an 8% SDS-polyacrylamide gel. The proteins were electrophoretically transferred onto a polyvinylidene difluoride membrane (Millipore Corp., Bedford, MA), and the membrane was blocked with 5% dry skim milk. The membrane was incubated with an anti-SR-BI antibody in a buffer consisting of 10 mM Tris-HCl (pH 8.0), 0.15 M NaCl, and 0.5% Tween 20; washed; reacted with an alkaline phosphatase-conjugated anti-rabbit IgG antibody (Bio-Rad); and subjected to a chemiluminescence reaction using the Immun-Star system (Bio-Rad).

Immunohistochemistry-- Cultured cell lines or Sertoli cells of 20-day-old rats were fixed with 4% paraformaldehyde/phosphate-buffered saline for 20 min at room temperature and blocked with 3% bovine serum albumin for 1 h at room temperature. The fixed cells were then mixed with an anti-SR-BI antibody and left at room temperature for 1 h. To detect the transcription factor Ad4-binding protein (Ad4BP) (37), the fixed Sertoli cells were further treated with 0.1% Triton X-100/phosphate-buffered saline, then with methanol for permeabilization of the plasma membrane, and finally with an anti-Ad4BP antibody (37) for 1 h at room temperature. The cells were supplemented with an FITC-conjugated anti-rabbit IgG antibody (Immunotech, Marseilles, France) for 30 min at room temperature and examined under a fluorescence/phase-contrast microscope.

    RESULTS

Preparation of Spermatogenic Cell Populations with Distinct Ploidy-- The cells present in seminiferous tubules of either 20- or 45-day-old rats were dispersed by successive treatment with trypsin and collagenase and subjected to a Percoll density gradient. The morphology of the separated cells was examined by microscopy, and cells with similar morphology were combined. When the combined cells were subjected to DNA flow cytometry, cell populations with distinct ploidy were found at 60-90% purity (Fig. 1A). The cells were eluted from the gradient in the order of 4n-, 1n-, 2n-, and 1n-rich populations; 1n-rich cells were recovered in two different populations. 2n- and 4n-rich cell populations were obtained from 20-day-old rats, and 1n- and 2n-rich cell populations from 45-day-old rats. The separated cell populations were distinctive in appearance, and morphological examination allowed us to identify particular spermatogenic cell types, i.e. 1n-rich cells (first elution) consisted of round spermatids, 1n-rich cells (second elution) contained many elongated spermatids, most 2n-rich cells were spermatogonia, and 4n-rich cells were spermatocytes (Fig. 1B). Testicular somatic cells, including Sertoli cells, were not recovered as a major population in any fraction, and they probably remained attached to the chamber wall of the separation apparatus.


View larger version (60K):
[in this window]
[in a new window]
 
Fig. 1.   Characterization of fractionated spermatogenic cells. A, DNA flow cytometry. Several fractions eluted from the Percoll gradient were combined based on their morphology, stained with propidium iodide, and analyzed in a flow cytometer. Arrows indicate the positions of 1n-, 2n- and 4n-cells. Numbers are the percentages of cells present in corresponding peaks. B, microscopic analysis. The cells were stained with Hoechst 33342 and examined under a fluorescence/phase-contrast microscope. Scale bar = 10 µm.

Phagocytosis of Fractionated Spermatogenic Cells by Sertoli Cells-- We first determined how efficiently the fractionated spermatogenic cells were phagocytosed by Sertoli cells. The cells were cultured without Sertoli cells for 14-15 h to remove residual contamination of somatic cells that adhered to the culture container. The cultured spermatogenic cells, the viability of which was 80-90% as determined by trypan blue exclusion, were subjected to a phagocytosis assay with isolated rat Sertoli cells. Sertoli cells prepared from 20-day-old rats phagocytosed 2n- and 4n-rich cells of 20-day-old rats as efficiently as they did unfractionated spermatogenic cells (Fig. 2A). Similarly, 1n- and 2n-rich cells prepared from 45-day-old rats were almost equally phagocytosed by Sertoli cells from 20-day-old rats (Fig. 2B). These results showed that spermatogenic cells at various stages of differentiation were phagocytosed by Sertoli cells with similar efficiencies.


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 2.   Phagocytosis of fractionated spermatogenic cells by Sertoli cells. Unfractionated and fractionated spermatogenic cells prepared from 20-day-old (A) and 45-day-old (B) rats were subjected to a phagocytosis assay with Sertoli cells of 20-day-old rats. The differences among the phagocytosis efficiencies of the various cell populations were statistically assessed by analysis of variance.

Involvement of PS in Phagocytosis of Fractionated Spermatogenic Cells-- We previously showed that PS was translocated from the inner to the outer leaflet of the membrane bilayer of unfractionated spermatogenic cells of 20-day-old rats during culture without Sertoli cells and that liposomes containing PS inhibited phagocytosis of the spermatogenic cells by Sertoli cells (23). We thus examined whether PS externalization occurs in fractionated spermatogenic cells. Translocation of PS to the surface of the spermatogenic cells was determined using flow cytometry with FITC-labeled annexin V, which specifically binds to PS (38). All spermatogenic cell populations examined showed the presence of annexin V-bound cells, although the content differed among the populations (Fig. 3A), indicating that PS externalization occurs in apoptotic spermatogenic cells at all stages of differentiation.


View larger version (35K):
[in this window]
[in a new window]
 
Fig. 3.   PS-mediated phagocytosis of fractionated spermatogenic cells by Sertoli cells. A, exposure of PS on the cell surface. Spermatogenic cell populations were analyzed by flow cytometry for the binding of FITC-labeled annexin V. Numbers are the percentages of annexin V-bound cells, indicated by horizontal bars. B, effect of PS-containing liposomes on phagocytosis. Phagocytosis assays were performed in the presence of liposomes composed of either PC only (PC) or a mixture of PC and PS (PS). Phagocytic activity was measured relative to that in a reaction with no added liposomes, which was taken as 100. Significance was determined using Student's t test. *, p < 0.002; **, p < 0.001.

We then examined the effect of PS-containing liposomes on phagocytosis of fractionated spermatogenic cells by Sertoli cells. As shown in Fig. 3B, the addition of PS-containing liposomes significantly reduced phagocytosis of 1n- and 2n-rich cells of 45-day-old rats as well as of 4n-rich cells of 20-day-old rats, whereas liposomes composed of PC alone had little effect. The inhibition by PS-containing liposomes of phagocytosis of 2n-rich cells from 20-day-old rats was not significant, but a decrease in the phagocytic index in the presence of the liposomes was reproducibly observed. These results indicated the involvement of PS in the phagocytosis of all apoptotic spermatogenic cells by Sertoli cells.

Identification of Sertoli Cell PS Receptor-- The above results suggested the presence of a molecule(s) that recognizes PS and induces phagocytosis on the surface of Sertoli cells. SR-BI (reviewed in Ref. 39) is a strong candidate for such a PS receptor since it recognizes PS (40, 41) and is present in the testis (32, 42-44). We first examined whether Sertoli cells contain SR-BI mRNA. Oligo(dT)-selected RNA from Sertoli cells and spermatogenic cells of 20-day-old rats was blot-hybridized with a hamster SR-BI cDNA probe. The RNA from both cell types showed a discrete signal whose size roughly corresponded to that of the rat ovary SR-BI mRNA (45) (Fig. 4). This indicated that rat Sertoli cells express a gene coding for SR-BI. We then isolated an SR-BI cDNA by screening a library prepared from Sertoli cell mRNA using the hamster SR-BI cDNA as a hybridization probe. Three positive clones were obtained, and sequence analyses of two clones revealed one to be a part of the other. The longer clone included the entire coding region, and the primary sequence of rat Sertoli SR-BI2 was found to be identical to that of rat ovary SR-BI (45).


View larger version (41K):
[in this window]
[in a new window]
 
Fig. 4.   Presence of SR-BI mRNA in Sertoli cells. Total RNA (lanes 1 and 4) and poly(A)-containing RNA (lanes 2, 3, 5, and 6) (2.5 µg each) from Sertoli (lanes 1, 2, 4, and 5) and spermatogenic (lanes 3 and 6) cells of 20-day-old rats were analyzed on Northern blots with probes of the hamster SR-BI cDNA (lanes 1-3) and human beta -actin pseudogene DNA (lanes 4-6). The positions of 28 S and 18 S rRNAs are shown with arrowheads.

To determine the function of Sertoli cell SR-BI, the cDNA was introduced into Sertoli cell-derived cultured cell lines 15P-1 and TM4. From the cells that remained alive in G418-containing medium, 14 clones of 15P-1 and 30 clones of TM4 cells were isolated. They were first examined for the ability to incorporate fluorescence-labeled PS-containing liposomes by flow cytometry. The five 15P-1 clones and the 10 TM4 clones tested incorporated PS-containing liposomes more efficiently than the corresponding parental cells (Fig. 5A). The SR-BI mRNA was detectable in both parental cell lines (Fig. 5B). When parental cells and transfectants were immunohistochemically examined for the presence of SR-BI with anti-SR-BI-110, extranuclear localization of the protein was observed in all of them, and all the transfectants examined were found to contain more SR-BI than the corresponding parental cells (Fig. 5C). These cell clones were then subjected to a phagocytosis assay with apoptotic spermatogenic cells. Both parental cell lines possessed activity for phagocytosing spermatogenic cells in a PS-dependent manner (Fig. 5D). When the selected transfectants were tested, all showed higher activity levels of PS-mediated phagocytosis than the parental cells; the extent of the increase in the activity caused by SR-BI expression was not large, but was significant (Fig. 5D). The levels of activity of engulfing latex beads were comparable among parental cells and transfectants (data not shown). The above results indicated that overexpression of SR-BI confers the PS-mediated phagocytic activity of apoptotic spermatogenic cells on Sertoli cell-derived cell lines.


View larger version (54K):
[in this window]
[in a new window]
 
Fig. 5.   Function of SR-BI in Sertoli cell-derived cell lines. The rat Sertoli SR-BI cDNA was introduced into Sertoli cell-derived cell lines TM4 and 15P-1. The activities of incorporating PS-containing liposomes and phagocytosing apoptotic spermatogenic cells and the presence of SR-BI in cloned transfectants were determined. A, incorporation of fluorescence-labeled PS-containing liposomes. Solid lines, parental cells; broken lines, cell clones derived from TM4 (left panels) and 15P-1 (right panels). B, presence of SR-BI mRNA in parental cells. Poly(A)-containing RNA (2.5 µg) of 15P-1 (lane 1) and TM4 (lane 2) cells was analyzed on Northern blots with the hamster SR-BI cDNA as a probe. C, presence of SR-BI protein in transfectants. The cells were treated with an anti-SR-BI antibody and an FITC-labeled secondary antibody, and the signals were visualized under a fluorescence microscope. Scale bar = 10 µm. D, phagocytosis of spermatogenic cells. Phagocytic indices and effects of PS- and PC-containing liposomes (1 mM) were determined for each cell clone. Significance was determined using Student's t test. *, p < 0.05; **, p < 0.02; ***, p < 0.002; ****, p < 0.001.

We next studied whether SR-BI is actually involved in spermatogenic cell phagocytosis by Sertoli cells. Sertoli cells were first examined for the presence of SR-BI protein. Membrane fractions prepared from primary cultured Sertoli cells and spermatogenic cells of 20-day-old rats were analyzed by Western blotting with anti-SR-BI-76 (Fig. 6A). A discrete signal with a molecular mass of ~70 kDa was detected in Sertoli cell proteins, and it disappeared in the presence of the antigen peptide, but not a peptide corresponding to another region of SR-BI. Moreover, the migration of the signal was almost the same as that of a signal detectable with rat liver proteins. SR-BI protein seemed much less abundant in spermatogenic cells than in Sertoli cells. When Sertoli cells were immunohistochemically examined with anti-SR-BI-110, many of the cells showed extranuclear signals, but at differing intensities (Fig. 6B). On the other hand, the nuclei of Sertoli cells appeared to be uniformly stained with an antibody specific to the transcription factor Ad4BP, which exists in Sertoli and Leydig cells of the testis (37). Treatment with control normal rabbit IgG did not produce signals (data not shown). These results indicated that SR-BI exists in rat Sertoli cells. The antibodies used here do not distinguish SR-BII (46) from SR-BI. Most of the signal was, however, likely to be derived from SR-BI since SR-BII is much less abundant than SR-BI in the testis (46). We then determined the effect of anti-SR-BI antibodies on phagocytosis of spermatogenic cells by Sertoli cells prepared from 20-day-old rats. The addition of anti-SR-BI-76 inhibited the phagocytosis reaction, whereas control normal rabbit IgG had a minimal effect (Fig. 6C). Anti-SR-BI-110 showed a similar inhibitory effect (data not shown). Significant levels of the phagocytic activity always remained in the presence of maximal amounts of the antibody, and the residual activity was reduced by the addition of PS-containing liposomes (Fig. 6D), indicating that some part of PS-mediated phagocytosis by Sertoli cells is resistant to anti-SR-BI antibodies. We next examined the effect of HDL, a specific ligand for SR-BI (39). HDL inhibited both phagocytosis of spermatogenic cells (Fig. 7A) and incorporation of PS-containing liposomes (Fig. 7B) by Sertoli cells of 20-day-old rats in a dose-dependent manner. All of the above results indicated that SR-BI acts as a phagocytosis-inducing PS receptor of Sertoli cells, but that a small portion of PS-mediated phagocytosis seems to be executed by a molecule(s) other than SR-BI.


View larger version (60K):
[in this window]
[in a new window]
 
Fig. 6.   Effect of anti-SR-BI antibody on phagocytosis by Sertoli cells. A, Western blotting of SR-BI protein. Membrane fractions from liver (50 µg of protein) (lanes 1, 4, and 6), primary cultured Sertoli cells (10 µg of protein) (lanes 2, 5, and 7), and spermatogenic cells (10 µg of protein) (lane 3) of 20-day-old rats were analyzed by Western blotting with anti-SR-BI-76. Peptides (7 pmol) corresponding to amino acid residues 76-95 (lanes 4 and 5) or amino acid residues 110-132 (lanes 6 and 7) of SR-BI were added to the reaction simultaneously with the primary antibody. Shown on the left are the positions of size markers. B, immunohistochemical analysis of Sertoli cells. Primary cultured Sertoli cells of 20-day-old rats were immunohistochemically examined with anti-SR-BI-110 or an anti-Ad4BP antibody. Fluorescence and phase-contrast microscopic views are shown. Scale bar = 10 µm. C, effect of an anti-SR-BI antibody and PS-containing liposomes on phagocytic activity of Sertoli cells. Left panel, phagocytosis of apoptotic spermatogenic cells by Sertoli cells of 20-day-old rats was performed in the presence of anti-SR-BI-76 or normal rabbit IgG. The extent of phagocytosis was measured and is shown relative to that in a reaction with no added antibodies, which was taken as 100. Right panel, anti-SR-BI-76 (3 µg) and PS-containing liposomes (0.5 mM) were added to the phagocytosis reaction either by themselves or simultaneously. Significance was calculated using Student's t test. *, p < 0.001.


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 7.   Effect of HDL on phagocytosis and liposome incorporation by Sertoli cells. A, effect of HDL on phagocytic activity of Sertoli cells. The phagocytosis reaction of apoptotic spermatogenic cells by Sertoli cells of 20-day-old rats was conducted in the presence of the indicated concentrations of HDL, and the extent of the reaction is shown relative to that in a control reaction with no added HDL, taken as 100. Vertical bars indicate the standard error. B, effect of HDL on incorporation of PS-containing liposomes by Sertoli cells. Incorporation of fluorescence-labeled PS-containing liposomes by Sertoli cells of 20-day-old rats was examined in the presence of HDL or unlabeled PS-containing liposomes (PS) (1 mM). Left panel, fluorescence microscopic views of liposome-incorporating Sertoli cells are shown. HDL was added at 800 µg/ml. Scale bar = 10 µm. Right panel, the level of the fluorescence signal was determined using a cooled charge coupled device camera and is shown relative to a control reaction, taken as 100.


    DISCUSSION

As has been suggested from histochemical examination, apoptotic spermatogenic cells at all stages of differentiation were phagocytosed by Sertoli cells in vitro. This indicated that Sertoli cells are capable of phagocytosing all types of spermatogenic cells undergoing apoptosis during spermatogenesis. Moreover, the present results showed that all the apoptotic spermatogenic cells examined were recognized by Sertoli cells via PS exposed on the surface of the dying cells. This suggests that the apoptotic pathway and mode of subsequent recognition by Sertoli cells are common to all degenerating spermatogenic cells regardless of their state of differentiation.

Membrane phospholipids of normal cells are localized asymmetrically on the membrane bilayer, i.e. PC and sphingomyelin are mostly present in the outer leaflet, whereas other phospholipids, including PS and phosphatidylethanolamine, are restricted to the inner leaflet (reviewed in Refs. 47 and 48). If such asymmetry is lost upon induction of apoptosis, phospholipids that normally exist on the cytoplasmic side of the plasma membrane would appear on the cell surface, serving as a marker of apoptotic cells (49, 50). Translocation of PS from the inner to the outer membrane leaflet has been reported in a variety of apoptotic cells such as thymocytes (51), vascular smooth muscle cells (52), neutrophils (53), spermatocytes (23), and some cultured cell lines (38, 50, 54-56); and in cytoplasts treated with an apoptosis-inducing reagent (57). We showed here that PS externalization occurs in apoptotic spermatogenic cells at all stages of differentiation. It is thus possible that a loss of membrane phospholipid asymmetry, at least with regard to PS, is a general feature of apoptotic cells.

It is still unclear how phagocytes discriminate between apoptotic and normal cells. Several approaches have been taken to resolve this issue, and it is presumed that certain molecules present on the surface of phagocytic cells are responsible for the recognition of apoptotic cells (reviewed in Refs. 3, 58, and 59). The externalization of PS is one of the earliest changes in apoptosing cells (reviewed in Refs. 48 and 60), and a role for externalized PS in the recognition of apoptotic cells by phagocytes has been demonstrated (reviewed in Refs. 3, 48, 58, and 59). The presence of a phagocyte receptor(s) that recognizes PS exposed on the surface of apoptotic cells has thus been postulated, and several molecules have been identified as candidates (Ref. 61 and reviewed in Ref. 60); among them are class B scavenger receptors. We have provided evidence here that SR-BI, a member of the class B scavenger receptor family, is a Sertoli cell PS receptor responsible for phagocytosis of apoptotic spermatogenic cells. SR-BI has been shown to function as the PS-recognizing phagocytosis receptor in some cultured cell lines such as Chinese hamster ovary cells (41) and a human monocyte-derived cell line, THP-1 (62). It is thus likely that this particular member of the scavenger receptor family is the phagocytosis-inducing PS receptor common to the non-macrophage-type phagocytic cells. Since antibody inhibition of phagocytic activity of Sertoli cells was only partial and the residual activity was inhibitable by PS-containing liposomes, the presence of another phagocytosis-inducing PS receptor is presumed. We previously showed that integrin is not involved in the phagocytosis reaction by Sertoli cells (23). Lectins are not likely to participate in the recognition between Sertoli cells and spermatogenic cells either since the addition of GlcNAc, GlcN, GalN, or Glc at 20 mM did not affect the phagocytosis reaction (data not shown). Other approaches should be taken to identify this additional phagocytosis receptor of Sertoli cells. The level of SR-BI expression did not appear to be uniform among Sertoli cells of 20-day-old rats. This suggests that their phagocytic activity varies at different spermatogenic stages.

    ACKNOWLEDGEMENTS

We thank M. Hoshi and M. Matsumoto for allowing us to use the Celsep apparatus; F. Cuzin for the 15P-1 cells; K. Morohashi for the anti-Ad4BP antibody; and T. Haneji and T. Hirose for help in identifying spermatogenic cell types and Western blotting, respectively.

    FOOTNOTES

* This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Science, Sports, and Culture of Japan; a grant from the Organized Research Combination System of the Science and Technology Agency of Japan; a grant from the Japan Society for the Promotion of Science; a Sasakawa scientific research grant from the Japan Science Society; and a grant from Ofukai (the Alumnae Association of Japan Women's University).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

parallel To whom correspondence and reprint requests should be addressed: Faculty of Pharmaceutical Sciences, Kanazawa University, Takara-machi, Kanazawa, Ishikawa 920-0934, Japan. Tel.: 81-76-234-4481; Fax: 81-76-234-4480; E-mail: nakanaka{at}kenroku.kanazawa-u.ac.jp.

2 The nucleotide sequence for the rat Sertoli cell SR-BI cDNA has been deposited in the DDBJ/GenBankTM/EMBL nucleotide sequence data bases with accession number AB002151.

    ABBREVIATIONS

The abbreviations used are: PS, phosphatidylserine; FITC, fluorescein isothiocyanate; HDL, high density lipoprotein; PC, phosphatidylcholine; SR-BI, class B scavenger receptor type I; Ad4BP, Ad4-binding protein.

    REFERENCES
Top
Abstract
Introduction
References
  1. Wyllie, A. H., Kerr, J. F. R., and Currie, A. R. (1980) Int. Rev. Cytol. 68, 251-306[Medline] [Order article via Infotrieve]
  2. Ellis, R. E., Yuan, J., and Horvitz, H. R. (1991) Annu. Rev. Cell Biol. 7, 663-698[CrossRef]
  3. Ren, Y., and Savill, J. (1998) Cell Death Differ. 5, 563-568[CrossRef][Medline] [Order article via Infotrieve]
  4. Huckins, C. (1978) Anat. Rec. 180, 905-926
  5. Allan, D. J., Harmon, B. V., and Kerr, J. F. R. (1987) in Perspectives on Mammalian Cell Death (Petten, C. S., ed), pp. 229-258, Oxford University Press, London
  6. Dym, M. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 11287-11289[Free Full Text]
  7. Dunkel, L., Hirvonen, V., and Erkkilä, K. (1997) Cell Death Differ. 4, 171-179[CrossRef]
  8. Braun, R. E. (1998) Nat. Genet. 18, 202-204[Medline] [Order article via Infotrieve]
  9. Allan, D. J., Harmon, B. V., and Roberts, S. A. (1992) Cell Proliferation 25, 241-250[Medline] [Order article via Infotrieve]
  10. Kerr, J. B. (1992) J. Reprod. Fertil. 95, 825-830[Abstract]
  11. Shikone, T., Billig, H., and Hsueh, A. J. W. (1994) Biol. Reprod. 51, 865-872[Abstract]
  12. Brinkworth, M. H., Weinbauer, G. F., Schlatt, S., and Nieschlag, E. (1995) J. Reprod. Fertil. 105, 25-33[Abstract]
  13. Callard, G. V., Jorgensen, J. C., and Redding, J. M. (1995) Dev. Genet. 16, 140-147[Medline] [Order article via Infotrieve]
  14. Chemes, H. (1986) Endocrinology 119, 1673-1681[Abstract]
  15. Pineau, C., Le Magueresse, B., Courtens, J.-L., and Jégou, B. (1991) Cell Tissue Res. 264, 589-598[Medline] [Order article via Infotrieve]
  16. Miething, A. (1992) Cell Tissue Res. 267, 583-590[Medline] [Order article via Infotrieve]
  17. Russell, L. D., and Clermont, Y. (1977) Anat. Rec. 187, 347-366[Medline] [Order article via Infotrieve]
  18. Tokuda, N., Mano, T., and Levy, R. B. (1992) J. Urol. 147, 278-282[Medline] [Order article via Infotrieve]
  19. Rassoulzadegan, M., Paquis-Flucklinger, V., Bertino, B., Sage, J., Jasin, M., Miyagawa, K., van Heyningen, V., Besmer, P., and Cuzin, F. (1993) Cell 75, 997-1006[Medline] [Order article via Infotrieve]
  20. Grandjean, V., Sage, J., Ranc, F., Cuzin, F., and Rassoulzadegan, M. (1997) Dev. Biol. 184, 165-174[CrossRef][Medline] [Order article via Infotrieve]
  21. Byers, S., Jégou, B., MacCalman, C., and Blaschuk, O. (1993) in The Sertoli Cell (Russell, L. D., and Griswold, M. D., eds), pp. 461-476, Cache River Press, Clearwater, FL
  22. Mizuno, K., Shiratsuchi, A., Masamune, Y., and Nakanishi, Y. (1996) Cell Death Differ. 3, 119-123
  23. Shiratsuchi, A., Umeda, M., Ohba, Y., and Nakanishi, Y. (1997) J. Biol. Chem. 272, 2354-2358[Abstract/Free Full Text]
  24. Nagao, Y. (1989) In Vitro Cell. Dev. Biol. 25, 1088-1098[Medline] [Order article via Infotrieve]
  25. Tamaru, M., Nagao, Y., Taira, M., Tatibana, M., Masamune, Y., and Nakanishi, Y. (1990) Biochim. Biophys. Acta 1049, 331-338[Medline] [Order article via Infotrieve]
  26. Wolgemuth, D. J., Gizang-Ginsberg, E., Engelmyer, E., Gavin, B. J., and Ponzetto, C. (1985) Gamete Res. 12, 1-10[Medline] [Order article via Infotrieve]
  27. Martin, S. J., Reutelingsperger, C. P. M., and Green, D. R. (1996) in Techniques in Apoptosis: A User's Guide (Cotter, T. G., and Martin, S. J., eds), pp. 107-119, Portland Press Ltd., London
  28. Nishikawa, K., Arai, H., and Inoue, K. (1990) J. Biol. Chem. 265, 5226-5231[Abstract/Free Full Text]
  29. Basu, S. K., Goldstein, J. L., Anderson, R. G. W., and Brown, M. S. (1976) Proc. Natl. Acad. Sci. U. S. A. 73, 3178-3182[Abstract]
  30. Chomczynski, P., and Sacchi, N. (1987) Anal. Biochem. 162, 156-159[CrossRef][Medline] [Order article via Infotrieve]
  31. Ueyama, H., Hamada, H., Battula, N., and Kakunaga, T. (1984) Mol. Cell. Biol. 4, 1073-1078[Medline] [Order article via Infotrieve]
  32. Acton, S. L., Scherer, P. E., Lodish, H. F., and Krieger, M. (1994) J. Biol. Chem. 269, 21003-21009[Abstract/Free Full Text]
  33. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, 2nd Ed., Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
  34. Mather, J. P., Zhuang, L.-Z., Perez-Infante, V., and Phillips, D. M. (1982) Ann. N. Y. Acad. Sci. 383, 44-68[Medline] [Order article via Infotrieve]
  35. Kikuchi, H., Imajoh-Ohmi, S., and Kanegasaki, S. (1993) Biochim. Biophys. Acta 1162, 171-176[Medline] [Order article via Infotrieve]
  36. Jokinen, E. V., Landschulz, K. T., Wyne, K. L., Ho, Y. K., Frykman, P. K., and Hobbs, H. H. (1994) J. Biol. Chem. 269, 26411-26418[Abstract/Free Full Text]
  37. Morohashi, K., Zanger, U. M., Honda, S., Hara, M., Waterman, M. R., and Omura, T. (1993) Mol. Endocrinol. 7, 1196-1204[Abstract]
  38. Koopman, G., Reutelingsperger, C. P. M., Kuijten, G. A. M., Keehnen, R. M. J., Pals, S. T., and van Oers, M. H. J. (1994) Blood 84, 1415-1420[Abstract/Free Full Text]
  39. Rigotti, A., Trigatti, B., Babitt, J., Penman, M., Xu, S., and Krieger, M. (1997) Curr. Opin. Lipidol. 8, 181-188[Medline] [Order article via Infotrieve]
  40. Rigotti, A., Acton, S. L., and Krieger, M. (1995) J. Biol. Chem. 270, 16221-16224[Abstract/Free Full Text]
  41. Fukasawa, M., Adachi, H., Hirota, K., Tsujimoto, M., Arai, H., and Inoue, K. (1996) Exp. Cell Res. 222, 246-250[CrossRef][Medline] [Order article via Infotrieve]
  42. Landschulz, K. T., Pathak, R. K., Rigotti, A., Krieger, M., and Hobbs, H. H. (1996) J. Clin. Invest. 98, 984-995[Abstract/Free Full Text]
  43. Acton, S., Rigotti, A., Landschulz, K. T., Xu, S., Hobbs, H. H., and Krieger, M. (1996) Science 271, 518-520[Abstract]
  44. Varban, M. L., Rinninger, F., Wang, N., Fairchild-Huntress, V., Dunmore, J. H., Fang, Q., Gosselin, M. L., Dixon, K. L., Deeds, J. D., Acton, S. L., Tall, A. R., and Huszar, D. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 4619-4624[Abstract/Free Full Text]
  45. Mizutani, T., Sonoda, Y., Minegishi, T., Wakabayashi, K., and Miyamoto, K. (1997) Biochem. Biophys. Res. Commun. 234, 499-505[CrossRef][Medline] [Order article via Infotrieve]
  46. Webb, N. R., Connell, P. M., Graf, G. A., Smart, E. J., de Villiers, W. J. S., de Beer, F. C., and van der Westhuyzen, D. R. (1998) J. Biol. Chem. 273, 15241-15248[Abstract/Free Full Text]
  47. Zachowski, A. (1993) Biochem. J. 294, 1-14[Medline] [Order article via Infotrieve]
  48. Zwaal, R. F. A., and Schroit, A. J. (1997) Blood 89, 1121-1132[Free Full Text]
  49. Verhoven, B., Schlegel, R. A., and Williamson, P. (1995) J. Exp. Med. 182, 1597-1601[Abstract]
  50. Shiratsuchi, A., Osada, S., Kanazawa, S., and Nakanishi, Y. (1998) Biochem. Biophys. Res. Commun. 246, 649-655[CrossRef]
  51. Fadok, V. A., Voelker, D. R., Campbell, P. A., Cohen, J. J., Bratton, D. L., and Henson, P. M. (1992) J. Immunol. 148, 2207-2216[Abstract/Free Full Text]
  52. Bennett, M. R., Gibson, D. F., Schwartz, S. M., and Tait, J. F. (1995) Circ. Res. 77, 1136-1142[Abstract/Free Full Text]
  53. Liles, W. C., Kiener, P. A., Ledbetter, J. A., Aruffo, A., and Klebanoff, S. J. (1996) J. Exp. Med. 184, 429-440[Abstract]
  54. Martin, S. J., Reutelingsperger, C. P. M., McGahon, A. J., Rader, J. A., van Schie, R. C. A. A., LaFace, D. M., and Green, D. R. (1995) J. Exp. Med. 182, 1545-1556[Abstract]
  55. Casciola-Rosen, L., Rosen, A., Petri, M., and Schlissel, M. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 1624-1629[Abstract/Free Full Text]
  56. Fujimoto, I., Takizawa, T., Ohba, Y., and Nakanishi, Y. (1998) Cell Death Differ. 5, 426-431[CrossRef][Medline] [Order article via Infotrieve]
  57. Martin, S. J., Finucane, D. M., Amarante-Mendes, G. P., O'Brien, G. A., and Green, D. R. (1996) J. Biol. Chem. 271, 28753-28756[Abstract/Free Full Text]
  58. Savill, J., Fadok, V., Henson, P., and Haslettm, C. (1993) Immunol. Today 14, 131-136[CrossRef][Medline] [Order article via Infotrieve]
  59. Savill, J. (1997) Br. Med. Bull. 53, 491-508[Abstract]
  60. Fadok, V. A., Bratton, D. L., Frasch, S. C., Warner, M. L., and Henson, P. M. (1998) Cell Death Differ. 5, 551-562[CrossRef][Medline] [Order article via Infotrieve]
  61. Oka, K., Sawamura, T., Kikuta, K.-I., Itokawa, S., Kume, N., Kita, T., and Masaki, T. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 9535-9540[Abstract/Free Full Text]
  62. Murao, K., Terpstra, V., Green, S. R., Kondratenko, N., Steinberg, D., and Quehenberger, O. (1997) J. Biol. Chem. 272, 17551-17557[Abstract/Free Full Text]


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.